mebendazole has been researched along with paromomycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Botero, D | 1 |
| Stahel, E | 1 |
| Maki, J; Yanagisawa, T | 1 |
| Cline, BL | 1 |
3 review(s) available for mebendazole and paromomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Chemotherapy of human intestinal parasitic diseases.
Topics: Amebiasis; Amides; Ancylostomiasis; Ascariasis; Bephenium Compounds; Cestode Infections; Emetine; Furazolidone; Giardiasis; Humans; Hydroxyquinolines; Intestinal Diseases, Parasitic; Mebendazole; Metronidazole; Necatoriasis; Niclosamide; Oxyuriasis; Paromomycin; Piperazines; Pyrantel; Pyrimidines; Pyrvinium Compounds; Quinacrine; Strongyloidiasis; Tetramisole; Thiabendazole; Thiocyanates; Trichuriasis | 1978 |
Current drug regimens for the treatment of intestinal helminth infections.
Topics: Anthelmintics; Ascariasis; Cestode Infections; Helminthiasis; Hookworm Infections; Host-Parasite Interactions; Humans; Intestinal Diseases, Parasitic; Levamisole; Mebendazole; Niclosamide; Paromomycin; Piperazines; Pyrantel; Pyrvinium Compounds; Quinacrine; Strongyloidiasis; Tetrachloroethylene; Thiabendazole; Trichuriasis | 1982 |
5 other study(ies) available for mebendazole and paromomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Therapy of intestinal parasitoses].
Topics: Cestode Infections; Humans; Intestinal Diseases, Parasitic; Mebendazole; Nematode Infections; Niclosamide; Paromomycin; Pyrantel Pamoate; Pyrvinium Compounds; Thiabendazole | 1977 |
[Committee on anthelmintics. Residual group].
Topics: Animals; Anthelmintics; Arecoline; Arsenicals; Bithionol; Dichlorophen; Helminthiasis; Helminthiasis, Animal; Hexachlorophene; Mebendazole; Naphthoquinones; Niclofolan; Organophosphorus Compounds; Paromomycin; Piperidines; Plant Extracts; Rafoxanide; Thiocyanates; Toluidines | 1975 |
Anthelmintic effects of bithionol, paromomycin sulphate, flubendazole and mebendazole on mature and immature Hymenolepis nana in mice.
Topics: Animals; Anthelmintics; Bithionol; Dose-Response Relationship, Drug; Female; Hymenolepiasis; Hymenolepis; Mebendazole; Mice; Mice, Inbred ICR; Paromomycin; Phenols | 1985 |